Pediatric Constipation Medication
- Author: Stephen Borowitz, MD; Chief Editor: Carmen Cuffari, MD more...
Medication Summary
In several randomized trials, laxatives have been shown to be beneficial in the treatment of chronic childhood constipation.[21, 22] Studies have also shown that polyethylene glycol,[23] mineral oil, magnesium hydroxide, and lactulose are effective and can be used for prolonged time periods without risk.
The key to pharmacotherapy is to use a sufficient amount of laxative to produce the desired effect. The intermittent use of stimulant laxatives may be necessary in some children; however, routine usage of these agents in young children is not generally recommended. Continuous laxative therapy may be required for a number of months until the child extinguishes the association between pain and the passage of bowel movements.
Osmotic Laxatives
Class Summary
Osmotic laxatives produce an osmotic effect in the colon that results in distention and promotes peristalsis.
Polyethylene glycol (MiraLAX, Dulcolax Balance)
Polyethylene glycol (PEG) is a long chain of ethylene glycol molecules that results in an extremely large molecule. This agent is very poorly absorbed and functions as an osmotic laxative. The powders are tasteless and odorless and dissolve completely in nearly all liquids including water.
These agents often can also be used as purgatives in preparation for colonoscopy. At very large dosages, PEG is occasionally difficult to take and its usage may be associated with nausea, bloating, abdominal cramps, and vomiting.
Magnesium hydroxide (Philips' Milk of Magnesia, Fleet Pedia-Lax)
Magnesium is a divalent cation that is maximally absorbed in the distal small intestine. At low concentrations, magnesium appears to absorb by a saturable carrier-mediated process influenced by vitamin D. At higher concentrations, magnesium absorption appears to occur largely by diffusion and is quite inefficient. Increased serum magnesium levels may release cholecystokinin, which stimulates gastrointestinal motility and secretion; this may explain why some children experience abdominal cramping.
Magnesium is mostly flavorless but has a thick, chalky texture. It is made more palatable when mixed with a fluid (eg, milk, chocolate milk).
Lactulose (Constulose, Enulose, Generlac, Kristalose)
Lactulose is a synthetic, nonabsorbable disaccharide that is available as a 70% solution. This agent is generally very well tolerated and tastes sweet. Lactulose formulation contains 10 g lactulose/15 mL of oral solution.
Sorbitol
Sorbitol is an alcohol of glucose that is largely nonabsorbable. This agent is available as a 70% solution. As with lactulose, sorbitol is generally well tolerated and tastes quite sweet.
Magnesium citrate (Citroma)
Magnesium is a divalent cation that is maximally absorbed in the distal small intestine. At low concentrations, magnesium appears to absorb by a saturable carrier-mediated process influenced by vitamin D. At higher concentrations, magnesium absorption appears to occur largely by diffusion and is quite inefficient. Increased serum magnesium levels may release cholecystokinin, which stimulates gastrointestinal motility and secretion; this may explain why some children experience abdominal cramping.
Sodium acid phosphate (OsmoPrep, Visicol)
Phosphate is a divalent anion largely absorbed in the proximal small intestine. When this agent is administered as an enema, only small amounts are absorbed such that the phosphate functions as an osmotic agent. Each 15 mL contains 7.2 g monobasic sodium phosphate monohydrate and 2.7 g dibasic sodium phosphate heptahydrate.
Lubricants
Class Summary
Lubricating agents soften stools and decrease water absorption from the gastrointestinal tract. They may also promote salt and water secretion by the colon.
Mineral oil (Kondremul)
Mineral oil is a nonabsorbable fat that softens stool and decreases water absorption, partly by its metabolism in the colon to hydroxy fatty acids. This agent is largely tasteless and has an oily consistency that is made more palatable if it is cold or mixed into a fluid (eg, orange juice). When mineral oil is taken in high doses, many children experience seepage of orange oil into their underwear, which can produce perianal pruritus.
Stimulant Laxatives
Class Summary
Stimulant laxatives increase peristaltic activity in the gastrointestinal tract. Most of these agents also stimulate salt and water secretion in the colon.
Senna (Ex-Lax, Senokot, Fletcher's, Little Tummys)
Sennosides are plant alkaloids that stimulate colonic salt and water secretion and promote colonic motility. At higher doses, these agents often produce abdominal cramping. Long-term use in animals has not been associated with any evidence of cathartic colon, tachyphylaxis, or secondary hyperaldosteronism.
Bisacodyl (Dulcolax, Bisco-Lax)
Bisacodyl is a colorless and odorless compound that is very poorly absorbed. This agent can be administered orally or rectally. Bisacodyl increases colonic peristalsis and stimulates salt and water secretion.
Stool Softeners
Class Summary
Stool softening agents allow incorporation of water and fat into the stool, causing the stool to soften.
Docusate sodium (Colace, Docu-Soft, Diocto, DSS)
Docusate sodium is used to avoid straining during defecation. This agent allows incorporation of water and fat into the stool, causing it to soften.
Stool Softeners in Combination With Stimulants
Class Summary
Emollient stool softeners cause stool to soften. Stimulants increase peristaltic activity in the gastrointestinal tract. Most of both these types of agents also promote salt and water secretion by the colon.
Senna concentrate/docusate (Peri-Colace, Senokot, Dok Plus)
Docusate sodium allows incorporation of water and fat into the stool, causing it to soften. Casanthranol is an anthraquinone stimulant hydrolyzed by colonic bacteria into an active compound. Action is usually produced 8-12 hours after administration of this combination.
[Best Evidence] van den Berg MM, Benninga MA, Di Lorenzo C. Epidemiology of childhood constipation: a systematic review. Am J Gastroenterol. Oct 2006;101(10):2401-9. [Medline].
Borowitz SM, Cox DJ, Kovatchev B, et al. Treatment of childhood constipation by primary care physicians: efficacy and predictors of outcome. Pediatrics. Apr 2005;115(4):873-7. [Medline].
[Guideline] North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. Evaluation and treatment of constipation in children: summary of updated recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. Sep 2006;43(3):405-7. [Medline].
Benninga M, Candy DC, Catto-Smith AG, et al. The Paris Consensus on Childhood Constipation Terminology (PACCT) Group. J Pediatr Gastroenterol Nutr. Mar 2005;40(3):273-5. [Medline].
Issenman RM, Hewson S, Pirhonen D, et al. Are chronic digestive complaints the result of abnormal dietary patterns? Diet and digestive complaints in children at 22 and 40 months of age. Am J Dis Child. Jun 1987;141(6):679-82. [Medline].
Loening-Baucke V. Prevalence rates for constipation and faecal and urinary incontinence. Arch Dis Child. Jun 2007;92(6):486-9. [Medline].
Saps M, Sztainberg M, Di Lorenzo C. A prospective community-based study of gastroenterological symptoms in school-age children. J Pediatr Gastroenterol Nutr. Oct 2006;43(4):477-82. [Medline].
Yong D, Beattie RM. Normal bowel habit and prevalence of constipation in primary-school children. In: Ambulatory Child Health. Vol 4. 1998:277-82.
de Araujo Sant Anna AM, Calcado AC. Constipation in school-aged children at public schools in Rio de Janeiro, Brazil. J Pediatr Gastroenterol Nutr. Aug 1999;29(2):190-3. [Medline].
Borowitz SM, Cox DJ, Tam A, et al. Precipitants of constipation during early childhood. J Am Board Fam Pract. May-Jun 2003;16(3):213-8. [Medline].
De Lorijn F, Reitsma JB, Voskuijl WP, et al. Diagnosis of Hirschsprung's disease: a prospective, comparative accuracy study of common tests. J Pediatr. Jun 2005;146(6):787-92. [Medline].
Abrahamian FP, Lloyd-Still JD. Chronic constipation in childhood: a longitudinal study of 186 patients. J Pediatr Gastroenterol Nutr. Jun 1984;3(3):460-7. [Medline].
Loening-Baucke V. Polyethylene glycol without electrolytes for children with constipation and encopresis. J Pediatr Gastroenterol Nutr. Apr 2002;34(4):372-7. [Medline].
Bekkali NL, van den Berg MM, Dijkgraaf MG, et al. Rectal fecal impaction treatment in childhood constipation: enemas versus high doses oral PEG. Pediatrics. Dec 2009;124(6):e1108-15. [Medline].
Miller MK, Dowd MD, Friesen CA, Walsh-Kelly CM. A Randomized Trial of Enema Versus Polyethylene Glycol 3350 for Fecal Disimpaction in Children Presenting to an Emergency Department. Pediatr Emerg Care. Jan 20 2012;[Medline].
Pijpers MA, Tabbers MM, Benninga MA, Berger MY. Currently recommended treatments of childhood constipation are not evidence based: a systematic literature review on the effect of laxative treatment and dietary measures. Arch Dis Child. Feb 2009;94(2):117-31. [Medline].
Corkins MR. Are diet and constipation related in children?. Nutr Clin Pract. Oct 2005;20(5):536-9. [Medline].
Iacono G, Cavataio F, Montalto G, et al. Intolerance of cow's milk and chronic constipation in children. N Engl J Med. Oct 15 1998;339(16):1100-4. [Medline].
Lloyd B, Halter RJ, Kuchan MJ, et al. Formula tolerance in postbreastfed and exclusively formula-fed infants. Pediatrics. Jan 1999;103(1):E7. [Medline].
Vandenplas Y, Benninga M. Probiotics and functional gastrointestinal disorders in children. J Pediatr Gastroenterol Nutr. Apr 2009;48 Suppl 2:S107-9. [Medline].
Muller-Lissner SA. Adverse effects of laxatives: fact and fiction. Pharmacology. Oct 1993;47 Suppl 1:138-45. [Medline].
Schiller LR. Clinical pharmacology and use of laxatives and lavage solutions. J Clin Gastroenterol. Jan 1999;28(1):11-8. [Medline].
Dupont C, Leluyer B, Amar F, et al. A dose determination study of polyethylene glycol 4000 in constipated children: factors influencing the maintenance dose. J Pediatr Gastroenterol Nutr. Feb 2006;42(2):178-85. [Medline].
Khan S, Campo J, Bridge JA, et al. Long-term outcome of functional childhood constipation. Dig Dis Sci. Jan 2007;52(1):64-9. [Medline].

